Skip to main content
logo
Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0234
+0.0004 (1.74%)
At close: Oct 15, 2026

Bioxytran Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
388225944
Market Cap Growth
-58.01%4.49%-64.29%-63.00%33.18%89.57%
Enterprise Value
4109236047
Last Close Price
0.020.080.090.150.480.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
--3.15-4.35-7.04-17.93-14.04

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.24-0.48-0.61-0.62-0.66-0.67
Net Debt / Equity Ratio
-0.21-0.29-0.61-0.61-0.57-0.65
Net Debt / EBITDA Ratio
-0.28-0.40-0.49-0.50-0.88-
Quick Ratio
0.030.160.000.010.080.02
Current Ratio
0.030.160.000.010.080.02
Return on Assets (ROA)
-963.26%-290.70%-1002.88%-932.87%-545.10%-1181.99%
Return on Capital Employed (ROCE)
75.00%71.50%124.50%122.70%64.90%133.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-130.18%-26.04%-30.34%-20.47%-4.17%-9.09%
Buyback Yield / Dilution
-6.83%33.73%-3.45%-16.13%-8.57%-13.07%